Navigation Links
Velcade(R) Plus Doxil(R) Improves Previously Treated Multiple Myeloma Patients

NORTH HOLLYWOOD, Calif., and CHICAGO, The International Myeloma Foundation (IMF)-supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians-today said that data from a follow-up to a Phase 3 multi- national clinical trial shows the combination of DOXIL(R) with VELCADE(R) improves the probability of survival by 41%.

The follow-up study also showed no increase in serious side effects such as neuropathy with the addition of DOXIL to the VELCADE. The findings were presented at the American Society of Clinical Oncology (ASCO) global cancer meeting in Chicago.

The VELCADE/DOXIL combination was approved by the FDA just last month as a new treatment option for myeloma patients who have relapsed or who have not responded to at least one other course of treatment. The drugs work in combination because there is evidence that VELCADE increases the effectiveness of DOXIL against cancer cells and DOXIL does the same for VELCADE.

"'Improved survival' are words that every cancer patient wants to hear, and we are encouraged to have this new option to offer patients with peer reviewed data behind it," said Susie Novis, president and co-founder of the IMF. "Until there is a cure, we are moving myeloma toward becoming a chronic disease with long term survival achieved by using drugs in combination and in sequence. The VELCADE/DOXIL combination fits perfectly into this paradigm and offers an important and powerful new opportunity to extend and improve patients' lives."

DOXIL is a specially (liposomal) formulated version of the chemotherapy agent doxorubicin, and is approved for use in other forms of cancer. VELCADE, bortezomib, is approved for myeloma patients who have relapsed or not responded to a previous course of treatment. The findings come from a 14 month follow-up to a multi-national trial involving nearly 650 patients.

Myeloma, also called mul tiple myeloma, is a cancer of the bone marrow that affects production of red cells, white cells and stem cells. It affects an estimated 750,000 people worldwide, and in industrialized countries it is being diagnosed in growing numbers and in increasingly younger people.


'"/>




Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Sage Improves Memory
3. Combination Therapy Found To Improves Stroke Recovery
4. Caffeine Boosts Memory, Improves Attention Span
5. Children’s Health Improves By Swimmin
6. Fetal Neural Grafts Improves Motor and Cognitive Function in Huntington Patients
7. Folic Acid Improves Survival Rate Of Children With Birth Defects
8. Drug Combo Improves Performance Of Multiple Sclerosis Drug
9. Weight Training Improves Quality Of Life In Breast Cancer Patients
10. Ginseng Improves The Survival Rates Of Breast Cancer
11. Statin Therapy in Patients with Acute Coronary Syndrome Improves Survival
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... Coast Dental has a new way ... Dental Health Month and family dentist Yvonne Dorrian, DMD, is hosting a free seminar ... , located next to Target at 1207 North Peachtree Parkway in Peachtree City. Dr. ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... top-load case packer for pouches, bags, and flow wrapped products at WestPack 2015, ... and specialty product manufacturers step up to semi-automatic or fully-automatic case packing with ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... metro area, has selected the latest beneficiary of their ongoing community enrichment program. ... preventing bullying in area schools. Donations are now being accepted at: http://www.angelsanddoves.com/donate.html ...
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try using ... the health benefits of integrating clay into a daily diet are numerous, as clay ... speaker, Perry A~ has since dedicated her life to learning about the benefits of ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)...  A research team led by St. Jude ... how the abnormal breakage and rearrangement of chromosomes in ... acute lymphoblastic leukemia (ALL). Such leukemias are cancers of ... of immature cells, called lymphoblasts. --> ... underlying the type called "Ph-like ALL" will aid in ...
(Date:2/8/2016)... DIEGO , Feb. 8, 2016 /PRNewswire/--  Cell ... announced that advanced tissue-engineering services are now available ... a groundbreaking new three-dimensional (3D) bioprinting approach called ... 3D Bio Printer , a state-of-the-art robotic system ... has created a powerful pay-for-service bio-printing model that ...
(Date:2/8/2016)... 2016 http://www.researchandmarkets.com/research/bcrl3s/labelfree ... "Label-Free Detection Market by Technology, Products, ... report to their offering. --> ... the "Label-Free Detection Market by Technology, ... report to their offering. --> ...
Breaking Medicine Technology: